HIF1A and breast angiosarcoma: Surprisingly, Fratta et al. found that BA patients with a high expression of HIF1a and HIF2a had a significantly lower expression of VEGF-A and its related receptor, VEGFR2, than patients with a low expression of HIF1a and HIF2a.